05.07.2018
- The US Food and Drug Administration‘s (FDA) recent approval of a new migraine treatment marketed by Amgen and Novartis has met with an enthusiastic response since it was...
02.07.2018
- In a move that had been widely expected, Swiss drugs giant Novartis has announced that it will spin off its Alcon eye care division into a separate standalone company. The...
24.05.2018
- An ill-advised “advisory” deal with the personal attorney of US president Donald Trump continues to plague Swiss drugmaker Novartis. Two weeks ago the company made headlines when...
19.04.2018
- European drugmakers GlaxoSmithKline of the UK and Novartis of Switzerland have agreed to contribute to a nearly $4 billion global research effort to fight drug-resistant strains of...
11.04.2018
- In an all-cash deal expected to close in the second half of this year, Swiss drugs giant Novartis has agreed to pay $8.7 billion for AveXis, a US-based clinical stage gene therapy...
28.03.2018
- In a move that may explain why GlaxoSmithKline last week turned thumbs down on bidding for Pfizer’s consumer drugs business, the UK’s largest drugmaker has announced plans to buy...
21.11.2017
- European pharmaceutical industry heavyweights Novartis and Bayer are challenging a proposal by parts of the UK’s National Health Service (NHS) to allow patients with wet age...
13.11.2017
- Amid estimates that the business could be worth as much as $1.5 billion, speculation is mounting that Swiss drugmaker Novartis may be planning to sell its dermatology generics arm...